Caas Capital Management LP Rhythm Pharmaceuticals, Inc. Transaction History

Caas Capital Management LP

  • $836 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021
SELL
$11.68 - $20.72 $981,633 - $1.74 Million
-84,044 Closed
0 $0
Q2 2021

Aug 16, 2021
SELL
$18.52 - $22.55 $9.88 Million - $12 Million
-533,551 Reduced 86.39%
84,044 $1.65 Million
Q1 2021

May 17, 2021
BUY
$20.25 - $39.49 $12.5 Million - $24.4 Million
617,595 New
617,595 $13.1 Million

Others Institutions Holding RYTM

# of Institutions
192
Shares Held
67.3M
Call Options Held
834K
Put Options Held
78.6K
View Full List

About RHYTHM PHARMACEUTICALS, INC.

RYTM Quotes by TradingView
  • Ticker RYTM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,720,000
  • Market Cap $3.46B
  • Description
  • Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company's lead product candidate is IMCIVREE, a potent melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convert...
More about RYTM
Track This Portfolio

Track Caas Capital Management LP Portfolio

Follow Caas Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caas Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Caas Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email